Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis, +21

JAMA Internal Medicine

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Dimitrios Giannis, Steven L. Allen, James Tsang, +25

Blood

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients

Stuart L. Cohen, Eugenia Gianos, Mathew A. Barish, +9

Thrombosis and Haemostasis

Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China

Hong Shang, Xiaoxu Han, Xuanling Shi, +8

Journal of Biological Chemistry

GeneticsGenetic EpidemiologyImmunologySubtype BViral Evolution +14

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, +9

Research and Practice in Thrombosis and Haemostasis

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19

Dimitrios Giannis, Matthew A. Barish, Mark Goldin, +9

Journal of Thrombosis and Thrombolysis

ThrombosisVenous ThrombosisCardiovascular DiseaseGlobal HealthCovid-19 Pandemic +8

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH

Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, +6

Journal of Thrombosis and Haemostasis

Good Practice StatementsThrombosisAntithrombotic TherapyCovid-19 PandemicCoagulopathy +3

Genetic and Epidemiologic Characterization of HIV-1 Infection In Liaoning Province, China

Xiaoxu Han, Di Dai, Bin Zhao, +9

JAIDS Journal of Acquired Immune Deficiency Syndromes

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19

Mark Goldin, Stephanie K. Lin, Nina Kohn, +14

Journal of Thrombosis and Thrombolysis

ThrombosisPulmonary EmbolismExternal ValidationVenous DiseaseVenous Thrombosis +11

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial

Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, +8

Circulation